131 related articles for article (PubMed ID: 17588958)
1. Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain.
Banks GB; Gregorevic P; Allen JM; Finn EE; Chamberlain JS
Hum Mol Genet; 2007 Sep; 16(17):2105-13. PubMed ID: 17588958
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
3. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
[TBL] [Abstract][Full Text] [Related]
4. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
5. The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins.
Banks GB; Judge LM; Allen JM; Chamberlain JS
PLoS Genet; 2010 May; 6(5):e1000958. PubMed ID: 20502633
[TBL] [Abstract][Full Text] [Related]
6. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype.
Corrado K; Rafael JA; Mills PL; Cole NM; Faulkner JA; Wang K; Chamberlain JS
J Cell Biol; 1996 Aug; 134(4):873-84. PubMed ID: 8769413
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.
Liu M; Yue Y; Harper SQ; Grange RW; Chamberlain JS; Duan D
Mol Ther; 2005 Feb; 11(2):245-56. PubMed ID: 15668136
[TBL] [Abstract][Full Text] [Related]
9. Full-length dystrophin gene transfer to the mdx mouse in utero.
Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterisation of the actin-binding properties of utrophin.
Moores CA; Kendrick-Jones J
Cell Motil Cytoskeleton; 2000 Jun; 46(2):116-28. PubMed ID: 10891857
[TBL] [Abstract][Full Text] [Related]
11. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
12. An epitope structure for the C-terminal domain of dystrophin and utrophin.
Morris GE; Sedgwick SG; Ellis JM; Pereboev A; Chamberlain JS; Nguyen thi Man
Biochemistry; 1998 Aug; 37(31):11117-27. PubMed ID: 9693008
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
Judge LM; Haraguchiln M; Chamberlain JS
J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
[TBL] [Abstract][Full Text] [Related]
14. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
15. Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer.
Foster H; Sharp PS; Athanasopoulos T; Trollet C; Graham IR; Foster K; Wells DJ; Dickson G
Mol Ther; 2008 Nov; 16(11):1825-32. PubMed ID: 18766174
[TBL] [Abstract][Full Text] [Related]
16. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
17. Proximal dystrophin gene deletions and protein alterations in becker muscular dystrophy.
Novaković I; Bojić D; Todorović S; Apostolski S; Luković L; Stefanović D; Milasin J
Ann N Y Acad Sci; 2005 Jun; 1048():406-10. PubMed ID: 16154963
[TBL] [Abstract][Full Text] [Related]
18. Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy.
Warner LE; DelloRusso C; Crawford RW; Rybakova IN; Patel JR; Ervasti JM; Chamberlain JS
Hum Mol Genet; 2002 May; 11(9):1095-105. PubMed ID: 11978768
[TBL] [Abstract][Full Text] [Related]
19. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
[TBL] [Abstract][Full Text] [Related]
20. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
